Around 30 centres and hospitals in Catalonia are studying promising treatments of COVID-19
The “Corporación Catalana de Medios Audiovisuales” has published a report on the RiPCoN project, in which IRB Barcelona’s Structural Bioinformatics and Network Biology is participating.
Research centres in Catalonia drive 10 crowdfunding campaigns
Several media channels have reported on the fundraising campaign launched by IRB Barcelona to fund its four research projects on COVID-19.
Link to: eldiario.es
Laboratories in research centres to do rapid COVID-19 detection tests
Several media have reported on the platform set up by IRB Barcelona, the Center for Genomic Regulation (CRG) and the Institute for Bioengineering of Catalonia (IBEC) for mass testing for COVID-19, which seeks to contribute to halting the spread of the virus.
Felice Alessio Bava
IRB Barcelona Alumni member
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
Eduard Batlle
Group Leader
Group: Colorectal Cancer Laboratory
«We need to look at the soil, not at the seed. TGF-beta is the fertiliser that changes the earth in which the tumour seed grows.»
More info about this news here.
Lara Barrio
Research Associate
“From our study in Drosophila flies we can deduce that it would be particularly interesting to address vertebrates and analyse the participation of p53 in diabetes and obesity”
More on this news here
Laura Nevola
Alumni - Research Associate
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Jalaj Gupta
Postdoctoral Fellow
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Meritxell Teixidó
Research Associate
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
Laura Boulan
PhD Student
«I discovered that the bantam molecule drives the transition from larva to pupa, the phase analogous to human adolescence.»
More info about this news here.
